\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes Culture and society Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment Joint Research Center EIT Missions New European Bauhaus Horizon EuropeThe call for the New European Bauhaus 2022 Prizes is now open.
The New European Bauhaus 2022 Prizes will award young talents' ideas as well as existing projects for sustainability, inclusiveness and aesthetics bringing the European Green Deal to people and local communities.
Applications are open until 28 February 2022 at 19:00 CET.
More information can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
